“ Critical evaluation of the off-label indication and of the risks associated to the use of multi-dose vials on the treatment of age-related macular degeneration ” (2014) Brazilian Journal of Pharmaceutical Sciences, 50(1), pp. 63–72. doi:10.1590/S1984-82502011000100006.